1. Home
  2. VIR vs ASTE Comparison

VIR vs ASTE Comparison

Compare VIR & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$10.03

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

ASTE

Astec Industries Inc.

HOLD

Current Price

$61.07

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
ASTE
Founded
2016
1972
Country
United States
United States
Employees
N/A
4468
Industry
Biotechnology: Pharmaceutical Preparations
Construction/Ag Equipment/Trucks
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2019
2003

Fundamental Metrics

Financial Performance
Metric
VIR
ASTE
Price
$10.03
$61.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
1
Target Price
$19.43
$66.00
AVG Volume (30 Days)
2.1M
174.7K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
0.85%
EPS Growth
17.49
784.21
EPS
N/A
0.06
Revenue
$68,556,000.00
N/A
Revenue This Year
$270.22
$14.72
Revenue Next Year
N/A
$5.44
P/E Ratio
N/A
$1,029.00
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$37.83
52 Week High
$11.66
$65.69

Technical Indicators

Market Signals
Indicator
VIR
ASTE
Relative Strength Index (RSI) 60.72 66.19
Support Level $8.40 $47.67
Resistance Level $10.10 $61.22
Average True Range (ATR) 0.49 2.30
MACD 0.17 1.19
Stochastic Oscillator 79.78 79.52

Price Performance

Historical Comparison
VIR
ASTE

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: